Clinical trial
ALBION "Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet…
NCT00360386 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00360386 |
|---|---|
| Title | ALBION "Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis" |
| Official title | Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis. |
| Lead sponsor | Sanofi, Industry |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ischemia |
| Intervention type | Drug |
| Interventions | Clopidogrel |
| Enrollment | 110 |
| Start date | Mar 1, 2004 |
| Primary completion | Feb 1, 2005 |
| Completion | Feb 1, 2005 |
| First posted | Aug 4, 2006 |
| Last update posted | Aug 31, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: